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Th  erapeutic hypothermia has been shown to provide 
neuro  protection against ischemic injury after cardiac 
arrest in in vitro and in vivo models. In the previous issue 
of Critical Care, Meybohm and colleagues [1] demon-
strate that cardiac arrest triggers the release of cerebral 
inﬂ  ammatory cytokines in pigs’ cerebral cortex. Th  era-
peutic hypothermia alters inﬂ   ammatory response in 
cardiac arrest and subsequent cardiopulmonary resusci-
tation. Th   e combination of hypothermia with sevoﬂ  urane 
post-conditioning does not confer additional anti-
inﬂ  ammatory eﬀ  ects compared with hypothermia alone.
Cardiac arrest remains the leading cause of death in the 
US and Europe, with an out-of-hospital cardiac arrest 
survival-to-discharge rate of less than 10%. In-hospital 
cardiac arrest presents a dismal prognosis. According to 
a large in-hospital registry, the survival-to-discharge rate 
is 18%, whereas that of a developing country is 6.9% [2,3]. 
Without prompt care, the chance for meaningful survival 
falls dramatically within minutes of arrest onset. When 
immediate care is available and victims are successfully 
resuscitated, the majority of these initial survivors 
subsequently suﬀ  er crippling neurologic injury or die in 
the few days following the cardiac arrest event. Th  us, 
improving survival and brain function after initial 
resuscitation from cardiac arrest remains a critical 
challenge. Th  erapeutic hypothermia, introduced more 
than six decades ago, remains an impor  tant 
neuroprotective factor in cardiac arrest. Laboratory 
studies have demonstrated that cooling after resuscitation 
from cardiac arrest improves both survival as well as 
subsequent neurologic and cardiac function and has few 
side eﬀ  ects. Th  ese  ﬁ  ndings have been reproduced using a 
variety of cooling techniques in diﬀ  erent  species, 
including rats, dogs, and pigs.
However, physician use of hypothermia induction in 
patients resuscitated from cardiac arrest is low. In 2003, 
Abella and colleagues [4] reported that 87% of US 
physicians did not use therapeutic hypothermia following 
cardiac arrest. Various reasons for non-use were cited: 
49% felt that there were not enough data, 32% mentioned 
lack of incorporation of hypothermia into advanced 
cardiovascular life support protocols, and 28% felt that 
cooling methods were technically too diﬃ   cult  or  too 
slow. In 2002, a European group demonstrated an 
improve  ment in survival-to-discharge rate with favorable 
neurologic status in cooled patients, compared with 
normo  thermic patients surviving after cardiac arrest 
(53% versus 35%, respectively), and with no signiﬁ  cant 
adverse events from cooling; thereafter, induced hypo-
thermia was considered the best practice for patients 
following cardiac arrest [5]. In 2005, the American Heart 
Asso  ciation recommended the consideration of thera-
peutic hypothermia for unconscious adult patients with 
return of spontaneous circulation following out-of-
hospital cardiac arrest due to ventricular ﬁ  brillation. In 
2008, Binks and colleagues [6] reported that 85.6% of 
intensive care units in the UK were using hypothermia as 
part of post-cardiac arrest management.
Clinical observation demonstrated that tumor necrosis 
factor-alpha (TNFα) and interleukin-6 (IL-6) protein 
were increased in cerebrospinal ﬂ  uid following cardiac 
arrest [7]. Animal studies showed that inﬂ  ammatory 
markers were unregulated in rats’ hippocampus tissue 
and pigs’ serum and myocardial tissue after cardiac arrest 
[8-10]. Meybohm and colleagues [1] go further to 
demon strate  anti-inﬂ  ammatory and anti-apoptosis eﬀ  ects 
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upregulation expression of IL-1β, IL-6, IL-10, TNFα and 
intercellular adhesion molecule-1, Bcl-2, and Bax mRNA 
and IL-1β protein in cerebral cortex after cardiac arrest 
in a pig model.
Small reductions in core temperature lead to vaso-
constriction and shivering, eﬀ   ectively hindering hypo-
thermia. Th   us, prevention of vasoconstriction and shiver-
ing has become a major goal during induction of 
therapeutic hypothermia. Anesthetics and sedatives can 
lower the vasoconstriction and shivering threshold, thus 
allowing hypothermia. Sevoﬂ  urane pre-conditioning and 
early post-conditioning reduced both cerebral infarct size 
and neurological defect score, reduced impairment of 
hippocampus long-term potentiation resulting from 
myocardial ischemia, and increased nuclear factor 
inhibitory kappaBalpha content in THP-1 cells [11-13]. 
Sevoﬂ   urane pre-conditioning preserves myocardial 
function in patients undergoing coronary artery bypass 
graft surgery under cardiologic arrest [14]. An in vivo 
study showed that combination hypothermia with sevo-
ﬂ   urane attenuates the inﬂ   am  matory response during 
endotoxemia [15]. However, Meybohm and colleagues 
[1] could not provide evidence to support the view that 
sevoﬂ   urane post-conditioning confers additional anti-
inﬂ  ammatory eﬀ  ects in pigs’ cerebral cortex after cardio-
pulmonary resuscitation.
In summary, Meybohm and colleagues [1] provide 
useful evidence to support the clinical use of therapeutic 
hypothermia for cardiac arrest, but they did not study the 
anti-inﬂ  ammatory eﬀ  ects of sevoﬂ  urane in this model. It 
is even possible that in the setting of clinical practice, 
anesthetics may not provide signiﬁ  cant neuroprotection 
beyond that which is already being produced by thera-
peutic hypothermia. Th  us, at this time, it is diﬃ   cult to 
recommend anesthetics for the purpose of neuro-
protection in cardiac arrest.
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